Rinsho Shinkeigaku (Clinical Neurology)

Symposium 23

Cell therapy for brain diseases: Perspective and future prospects

Ryosuke Takahashi, M.D. and Takayuki Kondo, M.D.

Department of Neurology, Kyoto University Graduate School of Medicine

iPS cells have opened up a revolutionarily new era for disease researches and regenerative medicine. Disesespecific iPS cells have tremendous promise for the understanding of pathogenesis of numerous intractable brain diseases. Cell transplantation therapies using somatic stem cells, ES cells and iPS cells are also promising, although ethical issues should be cleared and a lot of problems should be solved by technical innovations before they go into clinics.
Full Text of this Article in Japanese PDF (526K)

(CLINICA NEUROL, 51: 1075|1077, 2011)
key words: iPS cells, ES cells, somatic stem cells, Parkinson's disease, cerebral infarction

(Received: 20-May-11)